Ticagrelor for renal insufficiency, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 19 Oct 2015: Trial registered, NCT02578537

The trials

NCT02578537: COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS

State
State not given
Phase
Phase 4
People
60 planned
Started
Oct 2015
Primary completion
Apr 2016
Arms
Ticagrelor group
Results
None posted
  1. 19 Oct 2015: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Brilinta, Brilique, Chewing Ticagrelor, Possia, Ticagrelor 180mg, Ticagrelor 45 mg, Ticagrelor 60mg, Ticagrelor 90mg, Ticagrelor 90mg for 6-month (immediately after PCI), Ticagrelor 90mg/60mg, Ticagrelor monotherapy, half-dose ticagrelor, low-dose ticagrelor.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.